BioSpace News Archive

An implantable pump is a technologically advanced drug delivery system or device implanted beneath the skin to administer a steady dose of drug or fluid.

The measles, mumps, and rubella vaccines market is observing significant growth due to high incidence of pneumococcal infections.

RNA-based biopharmaceuticals is a comparatively new class of treatment and it comprises vaccines and therapeutics.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its full-year 2020 financial results and provides an update on its business activities and outlook for 2021.

License with NIH for intellectual property for a clinically-validated, GMP grade feeder cell line to enable robust natural killer (NK) cell expansion

Acutus Medical announced the appointment of John Sheridan to the Company’s Board of Directors effective March 17, 2021.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage biopharmaceutical company focused on tissue protection, repair and regeneration, announced that the ARISE-3 Phase 3 clinical trial evaluating RGN-259 eyedrops for the treatment of dry eye syndrome

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, announced it will sponsor Citizen Scientist: Unpacking the Science of Sickle Cell Disease, an initiative developed by the Sickle Cell Community Consortium to promote health literacy for sickle cell patients.

Petros Pharmaceuticals, Inc. (Petros or the Company) (NASDAQ: PTPI), a leading provider of therapeutics for men’s health, today announced the publication of preliminary research on the investigational use of Stendra® (avanafil) for endothelial function in men with erectile dysfunction (ED).

McKesson, a global leader in healthcare dedicated to supporting the full continuum of care, announced the launch of ScriptPAS™, a pharmacy management solution for oncology practices powered by Biologics by McKesson specialty pharmacy.